ROG

Rogers Corporation (ROG) - Q2 2026 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended June 30, 2026. Rogers Corporation designs, develops, and manufactures high-performance engineered materials and components. The company operates through two primary segments: Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS), with a smaller "Other" segment. The company is a large accelerated filer headquartered in Chandler, Arizona.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Turnaround: The company returned to profitability in Q2 2026, contrasting sharply with the significant operating and net losses in Q2 2025. The prior year's loss was heavily impacted by a $67.3M goodwill impairment and $4.5M intangible asset impairment related to the curamik business, which did not recur in 2026.
• Revenue Growth: Net sales increased 6.9% QoQ and 6.1% YTD, driven by higher demand ($8.7M in Q2) and favorable currency impacts ($5.3M in Q2).
• Margin Expansion: Gross margin improved by 90 basis points in Q2 and 160 basis points YTD, attributed to higher sales volume, favorable product mix, and operational efficiencies from manufacturing footprint consolidation in Belgium and Germany.
• Expense Reduction: SG&A expenses decreased 13.0% in Q2 and 10.3% YTD due to reductions in professional services, compensation, and software costs.
• Restructuring: Restructuring and impairment charges dropped significantly from $76.1M in Q2 2025 to $0.7M in Q2 2026. Current charges relate to manufacturing footprint consolidation and executive leadership transitions.

Guidance, Outlook, and Risks

• Capital Expenditures: Management expects 2026 capital spending to range between $30.0M and $35.0M, funded by cash from operations and on-hand cash.
• Share Repurchases: The company repurchased 22,618 shares for $3.0M in Q2 2026. Approximately $48.8M remains available under the current repurchase program.
• Outlook: Management anticipates continued growth driven by organic business in aerospace/defense, automotive (EV/ADAS), and data center markets. They aim to further improve profitability through operational excellence and cost savings.
• Risks & Contingencies:
  • Asbestos Litigation: 389 claims outstanding as of June 30, 2026. The company maintains a liability of $57.1M and insurance recoverables of $52.7M. Costs are expected to be substantially covered by insurance.
  • Geopolitical & Trade: Risks include trade policy dynamics, tariffs, and supply chain disruptions, particularly in China, Germany, and other key manufacturing locations.
  • ERP Implementation: The company is in a multi-year transition to a new global ERP system, which carries execution risks.

Investor Verification Checklist

• Impairment Recurrence: Verify that the $71.8M impairment charge from Q2 2025 was a one-time event and assess the current valuation of the curamik business.
• Asbestos Exposure: Review the stability of the $52.7M insurance recoverable and the solvency of insurance carriers covering the $57.1M liability.
• China Exposure: Analyze the impact of geopolitical tensions on the 42% of AES sales and 24% of EMS sales derived from China.
• Margin Sustainability: Confirm if the 160 bps YTD gross margin expansion is sustainable given rising raw material costs mentioned in the filing.
• Cash Utilization: Monitor the deployment of the $48.8M remaining share repurchase authorization and the $30M+ in short-term investments.